Literature DB >> 851644

Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

B Osterud, S I Rapaport, K K Lavine.   

Abstract

This study was prompted by the observation that fresh platelet suspensions--prepared by gel filtration or albumin density gradient centrifugation--possessed only minimal factor V activity, whereas frozen-and-thawed platelet suspensions possessed striking factor V activity. Results of experiments with fresh suspensions suggested that unaltered platelets did not bind plasma factor V. The factor V activity of frozen-and-thawed platelet suspensions was markedly diminished after exposure to a factor V antibody, was not activated by thrombin, and was not associated with an increase in factor V antigen over that found in fresh platelet suspensions. Consequently, disruption by freezing and thawing must have resulted in the appearance of small amounts of an activated factor V molecule in platelet suspensions. Disrupted platelets were shown to activate native factor V, but an interaction between a platelet activator and traces of native factor V in fresh suspensions could not be demonstrated to account for the full activity of frozen-and-thawed suspensions. Apparently, therefore, platelets also contained an activated factor V molecule. Adding collagen, but not adenosine 5'-diphosphate to fresh platelet suspensions increased their factor V activity. Release of an activated platelet factor V molecule after exposure to collagen could represent a physiologically significant early step in hemostasis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851644

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.

Authors:  Ammon M Fager; Jeremy P Wood; Beth A Bouchard; Ping Feng; Paula B Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  Thrombin generation and secretion of platelet Factor 4 during blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.

Authors:  O-Ki Kwon; Ki Jae Lee; Moon Hee Han; Chang-Wan Oh; Dae Hee Han; Young Cho Koh
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

5.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Authors:  B Osterud; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  Subcellular localization and secretion of factor V from human platelets.

Authors:  C M Chesney; D Pifer; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.

Authors:  F Ayombil; S Abdalla; P B Tracy; B A Bouchard
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

9.  Human coagluation factor V purification and thrombin-catalyzed activation.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.

Authors:  M S Lipscomb; P N Walsh
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.